New research led by the Karolinska Instituet, Sweden and the University of Glasgow, Scotland, has identified a link between a human gene and the composition of human gastrointestinal bacteria.

In a study published as a letter to the journal Gut today, the team outline new evidence suggesting that the human genome may play a role in determining the makeup of the billions of microbes in the human gastrointestinal tract collectively known as the gut microbiota. 

Mauro D'Amato, Associate Professor at the Department of Biosciences and Nutrition at Karolinska Institutet, said: “The hypothesis that our genes contribute to tailor-make our microbiota is very attractive. We still do not know whether certain DNA variations can result in the assembling and perpetuation of specific microbiota profiles, and this may bear important implications for the potential to treat common diseases through therapeutic modification of the gut flora.”

The microbiota, which evolved over tens of thousands of years alongside their human hosts, constitutes a complex and diverse community whose exact composition varies from person to person. It has numerous beneficial physiological and nutritional effects for humans; however, alterations in its bacterial composition have been linked to health problems including obesity and Crohn’s disease.

Dr Christopher Quince, of the University of Glasgow’s School of Engineering, said: “We ran a statistical analysis on bacterial DNA sequenced from samples of intestinal tissue from 51 healthy people with no history of bowel conditions in relation to 30 specific genes. These genes have been shown to increase the risk of Crohn’s disease, and are likely to play an important role in gut-bacteria interactions.

“We found that DNA variation in one of these genes, known as IRGM, was associated with the presence of increased levels of a type of microbe known as Prevotella.”

The research thus suggests that the IRGM gene could play a role in influencing the overall makeup of an individual’s microbiota, pushing it towards Prevotella dominance instead of an alternative community dominated by a closely related bacteria, Bacteroides.

Medical researchers are already considering therapeutic strategies to treat diseases by restoring ‘normal’ intestinal flora in patients by using pharmacological or dietary changes to create specific modifications in the gut microbiota. Future research, expanding on the current study, could help to more effectively target these treatments.

Associate Professor D’Amato said: “Primarily a proof-of-concept investigation, our pilot study reinforces the idea that large-scale analyses should be undertaken to unravel how variation in the entire human genome relates to variation in the human microbiota.”

Dr Quince added: “This is a small study but it could have important implications. We’ve provided further evidence that the human microbiome may also depend on the human genome, which invites serious investigation in the future.”

The study was conducted by an international team of scientists from Karolinska Institutet, University of Glasgow, Stockholm University, KTH Royal Institute of Technology, University of Newcastle, Australia, and SciLifeLab.

For more information contact University of Glasgow Media Relations Office on 0141 330 3535 or email media@glasgow.ac.uk

 

Publication

Christopher Quince, Elin Lundin, Anna N Andreasson, Dario Greco,Joseph Rafter,Nicholas J Talley, Lars Agreus, Anders F Andersson, Lars Engstrand, Mauro D’Amato (2012). ‘The impact of Crohn’s disease genes on healthy human gut microbiota: a pilot study’.

Published in Gut online XXX. DOI: http://gut.bmj.com/content/early/2013/01/04/gutjnl-2012-304214.full.pdf

First published: 7 January 2013

<< January